9NEW SOM R S,MCA LISTER J C,SAEED M,et al.Transpup illary thermo therapy (TTT) for the treatment of choroidal neovascularization[J].Br J Ophthalmol,2001,85(2):173-178.
1Sundelin S, Wihlmark U, Nilsson SE, et al. Lipofuscin accumulation in cultured retinal pigment epithelial cells reduces their phagocytic capacity. Curt Eye Res 1998;17(8) :851-857.
2Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol 2003 ;21:335-376 9.
3Higgs R, Cormican P, Cahalane S, et al. Induction of a novel chicken Toll-like receptor following salmonella enterica serovar typh in urium infection. Infect Immun 2006 ;74 ( 3 ) : 1692-1698.
4Zyzak J, Matuszyk J, Siednienko J. Multilevel maturation of Toll-like receptor 9. Postepy Hig Med Dosw (Online) 2013 ;67 : 1034-1046 12.
5Zhu Y, Liang L, Qian D, et al . Increase in peripheral blood mononuclear cell Toll-like receptor 2/3 expression and reactivity to their ligands in a cohort of patients with wet age-related macular degeneration. Mol Vis 2013 ; 19 : 1826-1833 13.
6Kleinman ME, Kaneko H, Cho WG, et al . Short-interfering RNAs induce retinal degeneration via TLR3 and IRF3. Mol Ther 2012 ;20( 1 ) : 101-108 14.
7Fujimoto T, Sonoda KH, Hijioka K, et al Choroidal neovascularization enhanced by Chlamydia pneumoniae via Toll- like Receptor 2 in the retinal pigment epithelium. Invest Ophthalmol Vis Sci 2010;51(9) :4694-4702 15.
8Zareparsi S, Buraczynska M, Branham KE, et al . Toll-like receptor 4 variant D299G is associated with susceptibility to age-related macular degeneration. Hum Mol Genet 2005 ; 14 ( 11 ) : 1449-1455 16.
9Despriet DD, Bergen AA, Merriam JE, et al . Comprehensive analysis of the candidate genes CCL2, CCR2, and TLR4 in age-related macular degeneration. Invest Ophthalmol Vis Sci 2008 ;49( 1 ) :364-371 17.
10Zhou P, Fan L,Yu KD, et al . Toll-like receptor 3 C1234T may protect against geographic atrophy through decreased dsRNA binding capacity. FASEB J 2011 ;25 (10) :3489-3495 18.
